Home › Drug Resistant Epilepsy › NCT05493722
Optimization of Deep Brain Stimulation Parameters in Patients With Medically Refractory Epilepsy
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * medically refractory epilepsy * already have a deep brain stimulator in place Exclusion Criteria: * severe dementia at investigator discretion
About the study
Deep brain stimulation (DBS) is used to treat epilepsy in cases where patients are medically refractory and are not candidates for surgical resection. This therapy has been shown to be effective in seizure reduction, yet very few patients achieve the ultimate goal of seizure freedom. Implantable neural stimulators (INSs) have many parameters that may be adjusted, and could be tuned to achieve very patient specific therapies. This study will develop a platform for stimulation setting optimization based on power spectral density (PSD) measures.
What is being tested
- PS and OS stimulation order 1 (other)
- PS and OS stimulation order 2 (other)
- PS and OS stimulation order 3 (other)
Sponsor: University of Minnesota · Participants: 20 · Started: Sep 15, 2023
Contact the study team
- Alec Jonason · Phone: 612-624-3127
Official record on ClinicalTrials.gov — NCT05493722
Locations in the U.S.
| Minnesota | University of Minnesota, Minneapolis |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.